XML 37 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 893 $ (4,385)
Adjustment to reconcile net income (loss) to net cash provided by operating activities    
Amortization of loan discount, loan commitment and deferred financing fees 84 159
Depreciation expense 150 118
Amortization expense 67 67
Earnings from unconsolidated joint venture, net of distributions 50 48
Stock-based compensation 479 261
Loss on equity method investments carried at fair value 560 0
Deferred income tax benefit 0 (1,062)
Changes in operating assets and liabilities:    
Trade receivables (956) (400)
Trade receivables - related party (694) (2,950)
Deferred revenue (1,875) 1,875
Other assets 11 (410)
Accrued personnel 1,520 1,396
Accounts payable 240 1,054
Accrued liabilities 72 489
Net cash provided by operating activities of discontinued operations 7,793 16,590
Net cash provided by operating activities 8,394 12,850
Cash flows from investing activities:    
Contributions to equity method investments carried at fair value (1,200) 0
Distributions from equity method investments carried at fair value 1,525 0
Purchase of fixed assets (207) 0
Principal received on note receivable 27 0
Net cash used in investing activities of discontinued operations 0 (41)
Net cash provided by investing activities 145 (41)
Cash flows from financing activities:    
Proceeds from notes payable 0 210
Payments on notes payable (228) (3,108)
Loan financing costs (28) 0
Distributions to non-controlling interests 0 (1,750)
Proceeds from exercise of warrants 360 0
Taxes paid related to net share settlement of equity awards (35) (38)
Net cash used in financing activities from discontinued operations (5,951) (7,461)
Net cash used in financing activities (5,882) (12,147)
Net increase (decrease) in cash and cash equivalents 2,657 662
Cash and cash equivalents, beginning of period 854 192
Cash and cash equivalents, end of period 3,511 854
Supplemental cash flow information:    
Interest paid, net of interest capitalized 420 190
Income taxes paid 0 8
Supplemental disclosure for non-cash activity:    
Accrued liability settled through issuance of stock 141 131
Conversion of noncontrolling interest to CHCI equity 16,019 0
Gain on deconsolidation of Investors X recorded in APIC 682 0
Increase in operating lease right-of-use assets upon adoption of ASC 842 $ 170 $ 0
Issuance of stock in lieu of interest due $66 $599
Increase in Series C preferred stock upon conversion of CGF I & II $ 0 $ 6,751
Increase in Additional Paid in Capital upon conversion of CGF I & II 0 3,071
Extinguishment of Notes payable - due to affiliates, net of discount $ 0 $ (11,421)